LRMR
Larimar Therapeutics Inc
NASDAQ: LRMR · HEALTHCARE · BIOTECHNOLOGY
$4.06
-6.45% today
Updated 2026-04-30
Market cap
$461.24M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.27
Dividend yield
—
52W range
$2 – $6
Volume
5.0M
Larimar Therapeutics Inc (LRMR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | $4000.00 | $11000.00 | $12000.00 | — | $70000.00 | $212000.00 | $188000.00 | $261000.00 | $78000.00 | $155000.00 | $326000.00 | $272000.00 | $311000.00 | $318000.00 | $350000.00 |
| Gross profit | $-4000.00 | $-11000.00 | $-12000.00 | — | $-70000.00 | $-212000.00 | $-188000.00 | $-261000.00 | $-78000.00 | $-155000.00 | $-326000.00 | $-272000.00 | $-311000.00 | $-318000.00 | $-350000.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $11.40M | $11.54M | $9.56M | $27.39M | $54.62M | $39.77M | $41.74M | $49.53M | $20.79M | $31.41M | $38.40M | $24.25M | $27.67M | $73.28M | $154.22M |
| SG&A | — | — | — | $8.14M | $19.20M | $18.29M | $12.16M | $1.52M | $2.42M | $11.40M | $12.07M | $12.28M | $14.09M | $17.61M | $18.27M |
| Operating income | $-13.15M | $-13.79M | $-13.78M | $-35.53M | $-73.81M | $-57.12M | $-53.88M | $-62.72M | $-23.21M | $-42.80M | $-50.47M | $-36.53M | $-41.76M | $-90.89M | $-172.50M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-13.15M | $-13.77M | $-14.02M | $-35.53M | $-73.41M | $-57.44M | $-52.58M | $-60.81M | $-23.14M | $-42.65M | $-50.14M | $-36.21M | $-41.45M | $-90.57M | $-172.50M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-13.16M | $-13.78M | $-14.03M | $-35.53M | $-73.48M | $-57.65M | $-52.76M | $-61.07M | $-23.21M | $-42.80M | $-50.47M | $-36.53M | $-41.76M | $-90.89M | $-172.85M |
| Interest expense | — | $97000.00 | — | $870000.00 | $806000.00 | $347000.00 | $971000.00 | $246000.00 | $1.77M | $0.00 | $326000.00 | $318000.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-13.16M | $-13.88M | $-14.03M | $-36.57M | $-74.29M | $-57.88M | $-52.03M | $-61.37M | $-23.13M | $-42.33M | $-50.31M | $-34.18M | $-36.95M | $-80.60M | $-165.67M |
| Net income growth (YoY) | — | -5.5% | -1.1% | -160.7% | -103.1% | +22.1% | +10.1% | -18.0% | +62.3% | -83.0% | -18.9% | +32.1% | -8.1% | -118.1% | -105.5% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |